Hedge funds gained 1.16% in May, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 2.35% after five months.
"An easing of Ukrainian turmoil fears, central bank signals of continuing easy money policies, and renewed M&A activity set the stage for a positive month for most hedge fund strategies," says Sol Waksman, founder and president of BarclayHedge.
Go deeper with GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
All but one of Barclay’s 18 hedge fund indices had gains in May. The Barclay Emerging Markets Index jumped 2.68%, Equity Long Bias gained 1.04%, the Multi Strategy Index was up 0.88%, Healthcare & Biotechnology gained 0.87%, and Technology added 0.81%.
"As investors dialed up risk exposure, the emerging markets sector was a major beneficiary," says Waksman.
The only losing hedge fund strategy in May was Equity Short Bias, which was down 2.15%. Year to date, Equity Short Bias has lost 6.67%.
The Healthcare & Biotechnology Index leads all strategies with a 7.03% gain for the year. Distressed Securities are up 5.05%, Fixed Income Arbitrage has gained 4.13%, the Event Driven Index is up 4.06%, and Convertible Arbitrage has gained 2.81%.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe Technology Index is down 4.62% through May, Pacific Rim Equities have lost 2.22%, and Global Macro is down 1.07%.
The Barclay Fund of Funds Index gained 1.01% in May, and is now up 0.90% in 2014.
